Publications

Harris M, Scott LLF, Nguyen LM, Haws LC. 2007. Trends in elevated blood lead levels of U.S. children and associated demographic characteristics. Ann Epidemiol 17:748.

Urban JD, Clarke WP, von Zastrow M, Kobilka B, Nichols DE, Weinstein H, Javitch JA, Roth BL, Christopoulos A, Sexton PM, Miller KJ, Spedding M, and Mailman RB. 2007. Functional selectivity and classical concepts of quantitative pharmacology. J. Pharmacol Exp Therap. 320 (1): 1-13.

Harris M, Tachovsky JA, Williams ES, Scott LLF, Nguyen L, Haws LC. Risks posed by air pollutants in the Houston metropolitan area. Society for Risk Analysis Annual Meeting, San Antonio, TX, December 2007.

Urban JD, Vargas G, von Zastrow M, and Mailman RB. 2007. Aripiprazole has functionally selective actions at D2 receptor-mediated signaling pathways. Neuropsychopharmacology. 32 (1): 67-77.

Harris M, Haws LC, Tachosvky A, Williams ES, Nguyen LM, Scott LF. Interactive processes in toxicity assessments. Air Toxics Research: Implications of Research on Policies to Protect Public Health. Houston, TX, June 2007.

Haws LC, Scott LLF, Staskal DF, Harris MA, Finley BL. 2007. Dioxin-like compounds in workers at a primary magnesium production facility. Dioxin 2007, Tokyo, Japan, September 2007.

Haws LC, Scott LLF, Staskal DF, Harris M, Finley B. Evaluation of biomonitoring data for dioxin-like compounds in workers at a primary magnesium production facility. Society for Risk Analysis Annual Meeting, San Antonio, TX, December 2007.

Haws LC, Walker NJ, DeVito MJ, Birnbaum LS, Unice KM, Scott PK, Harris MA, Farland WH, Finley BL, Staskal DF. Development of weighted distributions of REPs for dioxin-like compounds (DLCs). Society of Toxicology 46th Annual Meeting. March 25-29, Charlotte, NC, 2007.

Mounho, B. Comparison of Nonclinical Toxicology Programs for Epidermal Growth Factor Antagonists for Cancer Therapy: Monoclonal Antibodies Vectibix® and Erbitux® vs. Small Molecules Iressa® and Tarceva®. Presented at BioSafe General Membership Annual Meeting. 2007.

Mounho, B. Therapeutic Biologics. Presenter and course director: Biologics Drug Development: An Integrated Overview of Manufacturing, Nonclinical, Clinical, and Regulatory Requirements, PERI Course. Bethesda, MD. 2007.